Hira Mian

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Dina Khalaf

Associate Professor

UNITED STATES

View details

Marcos de Lima

Ohio State University

UNITED STATES

View details

Rahul Banerjee

Assistant Professor, Division of Medical Oncology

UNITED STATES

View details

Hsien Seow

Associate Professor

McMaster University

CANADA

View details

Gwynivere Davies

Hematologist, Associate Professor (McMaster University)

CANADA

View details

Christopher Venner

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hira Mian

Research Interests

Explore related searches

Contact this professor

Articles (20)

Comparing the clinical trial efficacy versus real-world effectiveness of treatments for multiple myeloma: a population-based study.

A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma

Quadruplets in newly diagnosed transplant‐ineligible multiple myeloma

Evaluating early intervention in smoldering myeloma clinical trials: a systematic review

Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT)

Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)

Pomalidomide use and kidney outcomes in patients with relapsed/refractory multiple myeloma and chronic kidney disease: A real-world, population-based cohort study.

Tandem Autologous Stem Cell Transplantation Does Not Benefit High-Risk Myeloma Patients In The Maintenance Era: Real-world Results From The Canadian Myeloma Research Group Database

Still high risk? A review of translocation t(14;16) in multiple myeloma

Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database

Impact of Second Primary Malignancy Post-Autologous Transplantation on Outcomes of Multiple Myeloma: A CIBMTR Analysis.

Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population‐based cohort study

Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study.

Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis

Outcome of carfilzomib/pomalidomide‐based regimens after daratumumab‐based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database

Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies JACC: CardioOncology State-of-the-Art Review

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma

Collaborators (6)

Dina Khalaf

Marcos de Lima

Rahul Banerjee

Hsien Seow

Gwynivere Davies

Christopher Venner

Make your next move.